loading page

CF GLOBAL CARE: Collaboration Between Two CF Centers; University of Michigan, USA and Marmara University, Istanbul, Turkey before and during the COVID-19 Pandemic
  • +8
  • Samya Nasr,
  • Yasemin Gokdemir,
  • Ela Erdem Eralp,
  • Fazilet Karakoc,
  • Almala Ergenekon,
  • Christopher Tapley,
  • Sharyn Dagher,
  • Sandra Bouma,
  • Ozge Kenis-Coskun,
  • Damla Kocamaz ,
  • Bulent Karadag
Samya Nasr
University of Michigan

Corresponding Author:[email protected]

Author Profile
Yasemin Gokdemir
Marmara University
Author Profile
Ela Erdem Eralp
Marmara University Faculty of Medicine
Author Profile
Fazilet Karakoc
Marmara University Faculty of Medicine
Author Profile
Almala Ergenekon
Marmara University School of Medicine
Author Profile
Christopher Tapley
Michigan Medicine
Author Profile
Sharyn Dagher
Michigan Medicine
Author Profile
Sandra Bouma
Michigan Medicine
Author Profile
Ozge Kenis-Coskun
Dr Lufti Kirdar Kartal Egitim ve Arastirma Hastanesi
Author Profile
Damla Kocamaz
Marmara University
Author Profile
Bulent Karadag
Marmara University Faculty of Medicine
Author Profile


Solving the world’s health challenges requires multidisciplinary collaborations that bring together the talents, experiences, resources, and ideas from multiple sectors in low and middle-income countries (LMIC) and high -income countries (HIC). Cystic Fibrosis (CF) was thought to be a disease of Caucasian populations from European decent. However, it has been shown to affect people from all ethnic backgrounds. CF care varies significantly for people with CF (pw CF) from HIC with median survival approaching 50 years of age, to LMIC with pw CF dying in infancy or early childhood. To address the discrepancy in quality of care and outcomes, we report on a collaboration between our team at the University of Michigan cystic fibrosis center (UoM CFC), through support from the Middle East CF Association (MECFA) and the CF Foundation (CFF), and a CF center in Turkey (Marmara University CF Center, Istanbul) to address deficiencies and improve quality of care in that center. The collaboration has been successful in improving Ma CFC data and patient care. This partnership can be viewed as a model of collaboration to be duplicated in other Middle East Countries and LMIC to deliver optimal CF care.
09 Sep 2021Submitted to Pediatric Pulmonology
11 Sep 2021Submission Checks Completed
11 Sep 2021Assigned to Editor
14 Sep 2021Reviewer(s) Assigned
19 Oct 2021Review(s) Completed, Editorial Evaluation Pending
24 Oct 2021Editorial Decision: Revise Major
14 Jan 20221st Revision Received
17 Jan 2022Reviewer(s) Assigned
17 Jan 2022Submission Checks Completed
17 Jan 2022Assigned to Editor
11 Feb 2022Review(s) Completed, Editorial Evaluation Pending
16 Feb 2022Editorial Decision: Revise Minor
14 Apr 20222nd Revision Received
16 Apr 2022Submission Checks Completed
16 Apr 2022Assigned to Editor
16 Apr 2022Reviewer(s) Assigned
24 May 2022Review(s) Completed, Editorial Evaluation Pending
26 May 2022Editorial Decision: Revise Minor
02 Jun 20223rd Revision Received
03 Jun 2022Submission Checks Completed
03 Jun 2022Assigned to Editor
03 Jun 2022Reviewer(s) Assigned
16 Jun 2022Review(s) Completed, Editorial Evaluation Pending
17 Jun 2022Editorial Decision: Accept